Suchergebnisse - "Mok, T S K"

PubPharm (75)

1

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042 : pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Mok, T. | Lopes, G. | Cho, B. | +14

CommentIn: Ann Oncol. 2023 Apr;34(4):327-332. - PMID 37061249

2

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

3

Testing for COVID-19 in lung cancer patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Passaro, A. | Peters, S. | Mok, T. | +3

4

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Lin, G. | Li, C. | Li, P. | +29

5

Differences Between the East and the West in Managing Advanced-Stage Non-small Cell Lung Cancer

enthalten in: Clinical oncology (Royal College of Radiologists (Great Britain)) | 2020

von Lee, V. | Mok, T. | Goto, Y. | +6

6

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

enthalten in: Integrative cancer therapies | 2019

von Molassiotis, A. | Suen, L. | Cheng, H. | +8

7

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Nokihara, H. | Lu, S. | Mok, T. | +17

CommentIn: Ann Oncol. 2017 Nov 1;28(11):2627-2629. - PMID 29045544

8

The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression : A Matched-cohort Analysis

enthalten in: Clinical oncology (Royal College of Radiologists (Great Britain)) | 2017

von Chan, O. | Lee, V. | Mok, T. | +3

9

A Phase III study of atezolizumab with carboplatin plus etoposide in patients with extensive-stage small cell lung cancer (IMpower133)

enthalten in: Annals of oncology | 2016

von Horn, L. | Reck, M. | Mok, T. | +8

10

Afatinib (A) vs gefitinib (G) in patients (pts) with EGFR mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC): overall survival (OS) data from the phase IIb trial LUX-Lung 7 (LL7)

enthalten in: Annals of oncology | 2016

von Paz-Ares, L. | Tan, E. | Zhang, L. | +17

1
2
3
4
5
6
7
8
Nächster »
[8]